nodes	percent_of_prediction	percent_of_DWPC	metapath
Probenecid—ABCC11—Methotrexate—systemic scleroderma	0.126	0.154	CbGbCtD
Probenecid—SLCO1C1—Methotrexate—systemic scleroderma	0.0554	0.0675	CbGbCtD
Probenecid—SLC16A1—Methotrexate—systemic scleroderma	0.0554	0.0675	CbGbCtD
Probenecid—CYP2C8—Mometasone—systemic scleroderma	0.0478	0.0582	CbGbCtD
Probenecid—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.0395	0.0481	CbGbCtD
Probenecid—SLCO1A2—Prednisone—systemic scleroderma	0.0381	0.0464	CbGbCtD
Probenecid—SLC22A6—Captopril—systemic scleroderma	0.0367	0.0447	CbGbCtD
Probenecid—ABCC3—Methotrexate—systemic scleroderma	0.0348	0.0425	CbGbCtD
Probenecid—ALB—Captopril—systemic scleroderma	0.0313	0.0381	CbGbCtD
Probenecid—SLC22A11—Methotrexate—systemic scleroderma	0.0286	0.0349	CbGbCtD
Probenecid—SLC22A7—Methotrexate—systemic scleroderma	0.0272	0.0332	CbGbCtD
Probenecid—ABCC4—Methotrexate—systemic scleroderma	0.0266	0.0325	CbGbCtD
Probenecid—ALB—Mycophenolate mofetil—systemic scleroderma	0.0246	0.03	CbGbCtD
Probenecid—ABCB1—Lisinopril—systemic scleroderma	0.0218	0.0266	CbGbCtD
Probenecid—CYP2C9—Leflunomide—systemic scleroderma	0.0215	0.0262	CbGbCtD
Probenecid—ABCC1—Methotrexate—systemic scleroderma	0.0214	0.0261	CbGbCtD
Probenecid—ALB—Prednisone—systemic scleroderma	0.0197	0.024	CbGbCtD
Probenecid—SLCO1A2—Methotrexate—systemic scleroderma	0.0191	0.0233	CbGbCtD
Probenecid—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.019	0.0232	CbGbCtD
Probenecid—SLC2A9—skeletal joint—systemic scleroderma	0.0186	0.227	CbGeAlD
Probenecid—SLC22A8—Methotrexate—systemic scleroderma	0.0166	0.0203	CbGbCtD
Probenecid—ABCB1—Captopril—systemic scleroderma	0.0163	0.0199	CbGbCtD
Probenecid—ABCC2—Methotrexate—systemic scleroderma	0.0158	0.0193	CbGbCtD
Probenecid—ABCC6—dermis—systemic scleroderma	0.0131	0.159	CbGeAlD
Probenecid—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0129	0.0157	CbGbCtD
Probenecid—CYP2C19—Prednisone—systemic scleroderma	0.0128	0.0155	CbGbCtD
Probenecid—SLC22A6—Methotrexate—systemic scleroderma	0.0116	0.0141	CbGbCtD
Probenecid—ABCB1—Prednisone—systemic scleroderma	0.0103	0.0125	CbGbCtD
Probenecid—ALB—Methotrexate—systemic scleroderma	0.00987	0.012	CbGbCtD
Probenecid—CYP2C9—cardial valve—systemic scleroderma	0.00956	0.117	CbGeAlD
Probenecid—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.00771	0.0094	CbGbCtD
Probenecid—CYP3A4—Prednisone—systemic scleroderma	0.00617	0.00752	CbGbCtD
Probenecid—ABCB1—Methotrexate—systemic scleroderma	0.00516	0.00629	CbGbCtD
Probenecid—Nephrotic syndrome—Captopril—systemic scleroderma	0.004	0.0409	CcSEcCtD
Probenecid—PANX1—connective tissue—systemic scleroderma	0.00342	0.0418	CbGeAlD
Probenecid—Hepatic necrosis—Captopril—systemic scleroderma	0.00332	0.034	CcSEcCtD
Probenecid—SLC22A12—digestive system—systemic scleroderma	0.00326	0.0398	CbGeAlD
Probenecid—SLC2A9—connective tissue—systemic scleroderma	0.0031	0.0379	CbGeAlD
Probenecid—Aplastic anaemia—Pentoxifylline—systemic scleroderma	0.00239	0.0245	CcSEcCtD
Probenecid—PANX1—tendon—systemic scleroderma	0.00235	0.0287	CbGeAlD
Probenecid—PANX1—lung—systemic scleroderma	0.00206	0.0252	CbGeAlD
Probenecid—ABCC6—connective tissue—systemic scleroderma	0.00188	0.023	CbGeAlD
Probenecid—SLC2A9—lung—systemic scleroderma	0.00187	0.0228	CbGeAlD
Probenecid—Aplastic anaemia—Azathioprine—systemic scleroderma	0.00158	0.0162	CcSEcCtD
Probenecid—Haemolytic anaemia—Captopril—systemic scleroderma	0.00155	0.0159	CcSEcCtD
Probenecid—SLC16A7—tendon—systemic scleroderma	0.00126	0.0154	CbGeAlD
Probenecid—SLC10A1—digestive system—systemic scleroderma	0.00124	0.0151	CbGeAlD
Probenecid—Flushing—Pentoxifylline—systemic scleroderma	0.00119	0.0121	CcSEcCtD
Probenecid—ABCC6—lung—systemic scleroderma	0.00114	0.0139	CbGeAlD
Probenecid—SLC22A11—digestive system—systemic scleroderma	0.00113	0.0138	CbGeAlD
Probenecid—Aplastic anaemia—Mycophenolate mofetil—systemic scleroderma	0.00112	0.0115	CcSEcCtD
Probenecid—Pollakiuria—Captopril—systemic scleroderma	0.00112	0.0114	CcSEcCtD
Probenecid—SLC16A7—lung—systemic scleroderma	0.0011	0.0135	CbGeAlD
Probenecid—Toxic epidermal necrolysis—Azathioprine—systemic scleroderma	0.0011	0.0113	CcSEcCtD
Probenecid—SLC22A7—digestive system—systemic scleroderma	0.0011	0.0134	CbGeAlD
Probenecid—Haemolytic anaemia—Lisinopril—systemic scleroderma	0.0011	0.0112	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Captopril—systemic scleroderma	0.00107	0.011	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Leflunomide—systemic scleroderma	0.00104	0.0106	CcSEcCtD
Probenecid—Anaemia—Pentoxifylline—systemic scleroderma	0.00103	0.0105	CcSEcCtD
Probenecid—Leukopenia—Pentoxifylline—systemic scleroderma	0.000997	0.0102	CcSEcCtD
Probenecid—SLC22A2—digestive system—systemic scleroderma	0.00098	0.012	CbGeAlD
Probenecid—Haemolytic anaemia—Mycophenolate mofetil—systemic scleroderma	0.000963	0.00985	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Azathioprine—systemic scleroderma	0.000935	0.00956	CcSEcCtD
Probenecid—Pollakiuria—Leflunomide—systemic scleroderma	0.000922	0.00943	CcSEcCtD
Probenecid—Erythema multiforme—Captopril—systemic scleroderma	0.000917	0.00938	CcSEcCtD
Probenecid—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.000909	0.0093	CcSEcCtD
Probenecid—Flushing—Captopril—systemic scleroderma	0.0009	0.00921	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Lisinopril—systemic scleroderma	0.000894	0.00914	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Leflunomide—systemic scleroderma	0.000883	0.00903	CcSEcCtD
Probenecid—ABCC5—tendon—systemic scleroderma	0.000881	0.0107	CbGeAlD
Probenecid—Pollakiuria—Mycophenolic acid—systemic scleroderma	0.00088	0.009	CcSEcCtD
Probenecid—Anorexia—Pentoxifylline—systemic scleroderma	0.000867	0.00886	CcSEcCtD
Probenecid—Alopecia—Captopril—systemic scleroderma	0.000857	0.00876	CcSEcCtD
Probenecid—Haematuria—Leflunomide—systemic scleroderma	0.000849	0.00868	CcSEcCtD
Probenecid—SLC16A1—digestive system—systemic scleroderma	0.000842	0.0103	CbGeAlD
Probenecid—Haematuria—Mycophenolic acid—systemic scleroderma	0.00081	0.00828	CcSEcCtD
Probenecid—SLC16A1—tendon—systemic scleroderma	0.000801	0.00978	CbGeAlD
Probenecid—Erythema multiforme—Azathioprine—systemic scleroderma	0.0008	0.00818	CcSEcCtD
Probenecid—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00079	0.00808	CcSEcCtD
Probenecid—Anaphylactic shock—Mometasone—systemic scleroderma	0.000784	0.00802	CcSEcCtD
Probenecid—Anaemia—Captopril—systemic scleroderma	0.00078	0.00798	CcSEcCtD
Probenecid—ABCC3—digestive system—systemic scleroderma	0.000777	0.00948	CbGeAlD
Probenecid—ABCC5—lung—systemic scleroderma	0.000773	0.00943	CbGeAlD
Probenecid—Stevens-Johnson syndrome—Lisinopril—systemic scleroderma	0.000758	0.00776	CcSEcCtD
Probenecid—Erythema multiforme—Leflunomide—systemic scleroderma	0.000756	0.00773	CcSEcCtD
Probenecid—Alopecia—Azathioprine—systemic scleroderma	0.000748	0.00765	CcSEcCtD
Probenecid—Anorexia—Mometasone—systemic scleroderma	0.000748	0.00765	CcSEcCtD
Probenecid—Haematuria—Lisinopril—systemic scleroderma	0.000729	0.00746	CcSEcCtD
Probenecid—Urticaria—Pentoxifylline—systemic scleroderma	0.000722	0.00739	CcSEcCtD
Probenecid—Body temperature increased—Pentoxifylline—systemic scleroderma	0.000719	0.00735	CcSEcCtD
Probenecid—Alopecia—Leflunomide—systemic scleroderma	0.000706	0.00722	CcSEcCtD
Probenecid—SLC16A1—lung—systemic scleroderma	0.000703	0.00858	CbGeAlD
Probenecid—Pollakiuria—Mycophenolate mofetil—systemic scleroderma	0.000694	0.0071	CcSEcCtD
Probenecid—Anaphylactic shock—Captopril—systemic scleroderma	0.000689	0.00705	CcSEcCtD
Probenecid—Decreased appetite—Mometasone—systemic scleroderma	0.000682	0.00697	CcSEcCtD
Probenecid—Anaemia—Azathioprine—systemic scleroderma	0.000681	0.00696	CcSEcCtD
Probenecid—Alopecia—Mycophenolic acid—systemic scleroderma	0.000674	0.00689	CcSEcCtD
Probenecid—Pain—Mometasone—systemic scleroderma	0.000671	0.00686	CcSEcCtD
Probenecid—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00067	0.00685	CcSEcCtD
Probenecid—SLCO1A2—digestive system—systemic scleroderma	0.000667	0.00814	CbGeAlD
Probenecid—Leukopenia—Azathioprine—systemic scleroderma	0.000659	0.00675	CcSEcCtD
Probenecid—Anorexia—Captopril—systemic scleroderma	0.000657	0.00672	CcSEcCtD
Probenecid—Erythema multiforme—Lisinopril—systemic scleroderma	0.000649	0.00664	CcSEcCtD
Probenecid—ABCC3—lung—systemic scleroderma	0.000649	0.00792	CbGeAlD
Probenecid—Pruritus—Pentoxifylline—systemic scleroderma	0.000643	0.00658	CcSEcCtD
Probenecid—Anaemia—Leflunomide—systemic scleroderma	0.000643	0.00658	CcSEcCtD
Probenecid—ABCC4—digestive system—systemic scleroderma	0.000641	0.00783	CbGeAlD
Probenecid—Haematuria—Mycophenolate mofetil—systemic scleroderma	0.000639	0.00654	CcSEcCtD
Probenecid—Flushing—Lisinopril—systemic scleroderma	0.000637	0.00652	CcSEcCtD
Probenecid—Aplastic anaemia—Methotrexate—systemic scleroderma	0.000637	0.00652	CcSEcCtD
Probenecid—Leukopenia—Leflunomide—systemic scleroderma	0.000623	0.00637	CcSEcCtD
Probenecid—ABCC2—digestive system—systemic scleroderma	0.000621	0.00758	CbGeAlD
Probenecid—Body temperature increased—Mometasone—systemic scleroderma	0.00062	0.00634	CcSEcCtD
Probenecid—Anaemia—Mycophenolic acid—systemic scleroderma	0.000613	0.00627	CcSEcCtD
Probenecid—ABCC4—tendon—systemic scleroderma	0.00061	0.00745	CbGeAlD
Probenecid—Alopecia—Lisinopril—systemic scleroderma	0.000607	0.00621	CcSEcCtD
Probenecid—ABCB1—blood vessel—systemic scleroderma	0.000603	0.00736	CbGeAlD
Probenecid—SLC22A5—skin of body—systemic scleroderma	0.000601	0.00734	CbGeAlD
Probenecid—Dizziness—Pentoxifylline—systemic scleroderma	0.000601	0.00615	CcSEcCtD
Probenecid—Decreased appetite—Captopril—systemic scleroderma	0.000599	0.00613	CcSEcCtD
Probenecid—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000594	0.00608	CcSEcCtD
Probenecid—ABCC2—tendon—systemic scleroderma	0.000591	0.00721	CbGeAlD
Probenecid—Vomiting—Pentoxifylline—systemic scleroderma	0.000578	0.00591	CcSEcCtD
Probenecid—Dermatitis—Pentoxifylline—systemic scleroderma	0.000573	0.00586	CcSEcCtD
Probenecid—Headache—Pentoxifylline—systemic scleroderma	0.000569	0.00583	CcSEcCtD
Probenecid—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000568	0.00581	CcSEcCtD
Probenecid—SLCO1A2—lung—systemic scleroderma	0.000557	0.00679	CbGeAlD
Probenecid—Pruritus—Mometasone—systemic scleroderma	0.000555	0.00568	CcSEcCtD
Probenecid—Anaemia—Lisinopril—systemic scleroderma	0.000553	0.00565	CcSEcCtD
Probenecid—Body temperature increased—Captopril—systemic scleroderma	0.000545	0.00557	CcSEcCtD
Probenecid—Anorexia—Leflunomide—systemic scleroderma	0.000541	0.00554	CcSEcCtD
Probenecid—Nausea—Pentoxifylline—systemic scleroderma	0.00054	0.00552	CcSEcCtD
Probenecid—ABCC4—lung—systemic scleroderma	0.000536	0.00654	CbGeAlD
Probenecid—Leukopenia—Lisinopril—systemic scleroderma	0.000535	0.00547	CcSEcCtD
Probenecid—CYP2C19—digestive system—systemic scleroderma	0.000534	0.00651	CbGeAlD
Probenecid—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000532	0.00544	CcSEcCtD
Probenecid—ABCC1—tendon—systemic scleroderma	0.000521	0.00635	CbGeAlD
Probenecid—Anorexia—Mycophenolic acid—systemic scleroderma	0.000516	0.00528	CcSEcCtD
Probenecid—Vomiting—Mometasone—systemic scleroderma	0.000499	0.0051	CcSEcCtD
Probenecid—Dermatitis—Mometasone—systemic scleroderma	0.000494	0.00505	CcSEcCtD
Probenecid—Decreased appetite—Leflunomide—systemic scleroderma	0.000494	0.00505	CcSEcCtD
Probenecid—Headache—Mometasone—systemic scleroderma	0.000491	0.00503	CcSEcCtD
Probenecid—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000488	0.00499	CcSEcCtD
Probenecid—Pruritus—Captopril—systemic scleroderma	0.000487	0.00499	CcSEcCtD
Probenecid—Pain—Leflunomide—systemic scleroderma	0.000486	0.00497	CcSEcCtD
Probenecid—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000484	0.00495	CcSEcCtD
Probenecid—SLC22A5—digestive system—systemic scleroderma	0.000481	0.00587	CbGeAlD
Probenecid—Body temperature increased—Azathioprine—systemic scleroderma	0.000475	0.00486	CcSEcCtD
Probenecid—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000471	0.00482	CcSEcCtD
Probenecid—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000469	0.0048	CcSEcCtD
Probenecid—Nausea—Mometasone—systemic scleroderma	0.000466	0.00477	CcSEcCtD
Probenecid—Anorexia—Lisinopril—systemic scleroderma	0.000465	0.00476	CcSEcCtD
Probenecid—Pain—Mycophenolic acid—systemic scleroderma	0.000463	0.00474	CcSEcCtD
Probenecid—SLC22A5—tendon—systemic scleroderma	0.000458	0.00559	CbGeAlD
Probenecid—ABCC1—lung—systemic scleroderma	0.000457	0.00558	CbGeAlD
Probenecid—Dizziness—Captopril—systemic scleroderma	0.000456	0.00466	CcSEcCtD
Probenecid—Urticaria—Leflunomide—systemic scleroderma	0.000451	0.00461	CcSEcCtD
Probenecid—Body temperature increased—Leflunomide—systemic scleroderma	0.000449	0.00459	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000444	0.00454	CcSEcCtD
Probenecid—Hypersensitivity—Azathioprine—systemic scleroderma	0.000443	0.00453	CcSEcCtD
Probenecid—Vomiting—Captopril—systemic scleroderma	0.000438	0.00448	CcSEcCtD
Probenecid—Dermatitis—Captopril—systemic scleroderma	0.000434	0.00444	CcSEcCtD
Probenecid—Headache—Captopril—systemic scleroderma	0.000432	0.00441	CcSEcCtD
Probenecid—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000428	0.00438	CcSEcCtD
Probenecid—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000427	0.00437	CcSEcCtD
Probenecid—Decreased appetite—Lisinopril—systemic scleroderma	0.000424	0.00434	CcSEcCtD
Probenecid—Hypersensitivity—Leflunomide—systemic scleroderma	0.000418	0.00428	CcSEcCtD
Probenecid—Pain—Lisinopril—systemic scleroderma	0.000417	0.00427	CcSEcCtD
Probenecid—CYP2C9—digestive system—systemic scleroderma	0.000414	0.00505	CbGeAlD
Probenecid—Nausea—Captopril—systemic scleroderma	0.000409	0.00419	CcSEcCtD
Probenecid—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000407	0.00417	CcSEcCtD
Probenecid—SLC22A5—lung—systemic scleroderma	0.000402	0.0049	CbGeAlD
Probenecid—Pruritus—Leflunomide—systemic scleroderma	0.000402	0.00411	CcSEcCtD
Probenecid—Dizziness—Azathioprine—systemic scleroderma	0.000398	0.00407	CcSEcCtD
Probenecid—Urticaria—Lisinopril—systemic scleroderma	0.000388	0.00396	CcSEcCtD
Probenecid—Body temperature increased—Lisinopril—systemic scleroderma	0.000386	0.00395	CcSEcCtD
Probenecid—Pruritus—Mycophenolic acid—systemic scleroderma	0.000383	0.00392	CcSEcCtD
Probenecid—Vomiting—Azathioprine—systemic scleroderma	0.000382	0.00391	CcSEcCtD
Probenecid—Dermatitis—Azathioprine—systemic scleroderma	0.000379	0.00387	CcSEcCtD
Probenecid—Flushing—Prednisone—systemic scleroderma	0.000379	0.00387	CcSEcCtD
Probenecid—Headache—Azathioprine—systemic scleroderma	0.000377	0.00385	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000376	0.00385	CcSEcCtD
Probenecid—Dizziness—Leflunomide—systemic scleroderma	0.000375	0.00384	CcSEcCtD
Probenecid—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000372	0.0038	CcSEcCtD
Probenecid—Pain—Mycophenolate mofetil—systemic scleroderma	0.000366	0.00374	CcSEcCtD
Probenecid—Haematuria—Methotrexate—systemic scleroderma	0.000362	0.0037	CcSEcCtD
Probenecid—Vomiting—Leflunomide—systemic scleroderma	0.000361	0.00369	CcSEcCtD
Probenecid—Alopecia—Prednisone—systemic scleroderma	0.00036	0.00369	CcSEcCtD
Probenecid—Hypersensitivity—Lisinopril—systemic scleroderma	0.000359	0.00368	CcSEcCtD
Probenecid—Dizziness—Mycophenolic acid—systemic scleroderma	0.000358	0.00366	CcSEcCtD
Probenecid—Dermatitis—Leflunomide—systemic scleroderma	0.000358	0.00366	CcSEcCtD
Probenecid—Nausea—Azathioprine—systemic scleroderma	0.000357	0.00365	CcSEcCtD
Probenecid—Headache—Leflunomide—systemic scleroderma	0.000356	0.00364	CcSEcCtD
Probenecid—Pruritus—Lisinopril—systemic scleroderma	0.000345	0.00353	CcSEcCtD
Probenecid—Vomiting—Mycophenolic acid—systemic scleroderma	0.000344	0.00352	CcSEcCtD
Probenecid—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000341	0.00349	CcSEcCtD
Probenecid—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00034	0.00347	CcSEcCtD
Probenecid—Headache—Mycophenolic acid—systemic scleroderma	0.000339	0.00347	CcSEcCtD
Probenecid—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000338	0.00346	CcSEcCtD
Probenecid—Nausea—Leflunomide—systemic scleroderma	0.000337	0.00345	CcSEcCtD
Probenecid—Anaemia—Prednisone—systemic scleroderma	0.000328	0.00336	CcSEcCtD
Probenecid—Dizziness—Lisinopril—systemic scleroderma	0.000323	0.0033	CcSEcCtD
Probenecid—Erythema multiforme—Methotrexate—systemic scleroderma	0.000322	0.0033	CcSEcCtD
Probenecid—Nausea—Mycophenolic acid—systemic scleroderma	0.000322	0.00329	CcSEcCtD
Probenecid—CYP3A4—digestive system—systemic scleroderma	0.000315	0.00385	CbGeAlD
Probenecid—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000315	0.00322	CcSEcCtD
Probenecid—Vomiting—Lisinopril—systemic scleroderma	0.00031	0.00317	CcSEcCtD
Probenecid—Dermatitis—Lisinopril—systemic scleroderma	0.000307	0.00314	CcSEcCtD
Probenecid—Headache—Lisinopril—systemic scleroderma	0.000306	0.00313	CcSEcCtD
Probenecid—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000302	0.00309	CcSEcCtD
Probenecid—Alopecia—Methotrexate—systemic scleroderma	0.000301	0.00308	CcSEcCtD
Probenecid—Nausea—Lisinopril—systemic scleroderma	0.00029	0.00296	CcSEcCtD
Probenecid—Anaphylactic shock—Prednisone—systemic scleroderma	0.00029	0.00296	CcSEcCtD
Probenecid—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000283	0.00289	CcSEcCtD
Probenecid—Anorexia—Prednisone—systemic scleroderma	0.000276	0.00283	CcSEcCtD
Probenecid—Anaemia—Methotrexate—systemic scleroderma	0.000274	0.00281	CcSEcCtD
Probenecid—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000272	0.00278	CcSEcCtD
Probenecid—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000269	0.00275	CcSEcCtD
Probenecid—Headache—Mycophenolate mofetil—systemic scleroderma	0.000268	0.00274	CcSEcCtD
Probenecid—Leukopenia—Methotrexate—systemic scleroderma	0.000266	0.00272	CcSEcCtD
Probenecid—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000254	0.0026	CcSEcCtD
Probenecid—Decreased appetite—Prednisone—systemic scleroderma	0.000252	0.00258	CcSEcCtD
Probenecid—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000242	0.00248	CcSEcCtD
Probenecid—Anorexia—Methotrexate—systemic scleroderma	0.000231	0.00236	CcSEcCtD
Probenecid—Urticaria—Prednisone—systemic scleroderma	0.00023	0.00235	CcSEcCtD
Probenecid—Body temperature increased—Prednisone—systemic scleroderma	0.000229	0.00234	CcSEcCtD
Probenecid—ABCB1—digestive system—systemic scleroderma	0.000223	0.00273	CbGeAlD
Probenecid—Hypersensitivity—Prednisone—systemic scleroderma	0.000213	0.00218	CcSEcCtD
Probenecid—Decreased appetite—Methotrexate—systemic scleroderma	0.000211	0.00215	CcSEcCtD
Probenecid—Pain—Methotrexate—systemic scleroderma	0.000207	0.00212	CcSEcCtD
Probenecid—Pruritus—Prednisone—systemic scleroderma	0.000205	0.0021	CcSEcCtD
Probenecid—Urticaria—Methotrexate—systemic scleroderma	0.000192	0.00197	CcSEcCtD
Probenecid—Dizziness—Prednisone—systemic scleroderma	0.000192	0.00196	CcSEcCtD
Probenecid—Body temperature increased—Methotrexate—systemic scleroderma	0.000191	0.00196	CcSEcCtD
Probenecid—ABCB1—lung—systemic scleroderma	0.000186	0.00228	CbGeAlD
Probenecid—Vomiting—Prednisone—systemic scleroderma	0.000184	0.00188	CcSEcCtD
Probenecid—Dermatitis—Prednisone—systemic scleroderma	0.000183	0.00187	CcSEcCtD
Probenecid—Headache—Prednisone—systemic scleroderma	0.000182	0.00186	CcSEcCtD
Probenecid—Hypersensitivity—Methotrexate—systemic scleroderma	0.000178	0.00183	CcSEcCtD
Probenecid—Nausea—Prednisone—systemic scleroderma	0.000172	0.00176	CcSEcCtD
Probenecid—Pruritus—Methotrexate—systemic scleroderma	0.000171	0.00175	CcSEcCtD
Probenecid—Dizziness—Methotrexate—systemic scleroderma	0.00016	0.00164	CcSEcCtD
Probenecid—Vomiting—Methotrexate—systemic scleroderma	0.000154	0.00157	CcSEcCtD
Probenecid—Dermatitis—Methotrexate—systemic scleroderma	0.000153	0.00156	CcSEcCtD
Probenecid—Headache—Methotrexate—systemic scleroderma	0.000152	0.00155	CcSEcCtD
Probenecid—Nausea—Methotrexate—systemic scleroderma	0.000144	0.00147	CcSEcCtD
